Montika 4mg Sachet

Montika 4mg Sachet contains Montelukast as its active ingredient. Montelukast belongs to a class of medications known as leukotriene receptor antagonists. It works by blocking the action of leukotrienes, which are chemicals in the body that contribute to inflammation, bronchoconstriction (tightening of muscles around the airways), and mucus production in conditions such as asthma and allergic rhinitis.

Uses:

1. Asthma: Montika 4mg Sachet is used for the maintenance treatment of asthma in adults and children aged 12 months and older. It helps to prevent asthma symptoms and improve lung function.
2. Allergic Rhinitis: It is also indicated for the relief of symptoms of allergic rhinitis, such as nasal congestion, sneezing, runny nose, and itching of the nose and throat, in patients aged 6 months and older.
3. Exercise-Induced Bronchoconstriction: Montika 4mg Sachet may be used to prevent exercise-induced bronchoconstriction (EIB) in individuals aged 6 years and older.

Side Effects:

1. Headache: Headache is one of the most common side effects reported with Montika 4mg Sachet.
2. Gastrointestinal Upset: Some individuals may experience stomach pain, diarrhea, or nausea.
3. Fatigue: Feeling tired or fatigued may occur in some patients.
4. Dizziness: Dizziness or lightheadedness may occur rarely.
5. Mood Changes: Mood changes, including agitation, aggression, anxiety, and depression, have been reported, particularly in children.
6. Sleep Disturbances: Sleep disturbances, such as insomnia or abnormal dreams, may occur.
7. Allergic Reactions: Serious allergic reactions to Montika 4mg Sachet are rare but possible. Seek medical attention immediately if you experience symptoms such as rash, itching, swelling, severe dizziness, or trouble breathing.

Precautions:

1. Asthma Control: Montika 4mg Sachet should not be used to treat acute asthma attacks. It is intended for long-term control of asthma symptoms and should be taken regularly even when symptoms are well-controlled.
2. Neuropsychiatric Events: Monitor for neuropsychiatric events, especially in pediatric patients. Discontinue use if such events occur.
3. Churg-Strauss Syndrome: Rare cases of systemic eosinophilia, vasculitis, and worsening pulmonary symptoms have been reported with Montelukast. Patients should be monitored for these conditions.
4. Liver Function: Periodic monitoring of liver function may be recommended, especially in patients with pre-existing liver disease.
5. Pregnancy and Breastfeeding: The safety of Montika 4mg Sachet during pregnancy and lactation has not been established. Consult a healthcare professional before using it during these periods.

When Not to Use:

Montika 4mg Sachet is contraindicated in patients with a known hypersensitivity to Montelukast or any other components of the sachet. It should not be used to treat acute asthma attacks.

FAQ:

1. How should Montika 4mg Sachet be taken?
   • Montika 4mg Sachet is usually taken orally once daily in the evening with or without food, as directed by a healthcare professional.
2. Can Montika 4mg Sachet be used in infants?
   • Yes, Montika 4mg Sachet can be used in infants aged 12 months and older for the treatment of asthma.
3. Is Montika 4mg Sachet a steroid?
   • No, Montika 4mg Sachet is not a steroid. It belongs to a class of medications called leukotriene receptor antagonists, which work differently from corticosteroids commonly used in asthma treatment.
4. Can Montika 4mg Sachet be used for immediate relief of asthma symptoms?
   • No, Montika 4mg Sachet is not intended for the immediate relief of asthma symptoms during an acute attack. It is a maintenance medication used to control asthma symptoms over the long term. For immediate relief, a short-acting bronchodilator inhaler is typically used.